Bonada M, Pittarello M, De Fazio E, Gans A, Alimonti P, Slika H
Genes (Basel). 2024; 15(8).
PMID: 39202398
PMC: 11353413.
DOI: 10.3390/genes15081038.
Oraee-Yazdani S, Akhlaghpasand M, Rostami F, Golmohammadi M, Tavanaei R, Shokri G
Front Neurol. 2023; 14:1060180.
PMID: 37034076
PMC: 10075310.
DOI: 10.3389/fneur.2023.1060180.
Piantino M, Figarol A, Matsusaki M
Front Toxicol. 2022; 3:656254.
PMID: 35295158
PMC: 8915870.
DOI: 10.3389/ftox.2021.656254.
Archie S, Shoyaib A, Cucullo L
Pharmaceutics. 2021; 13(11).
PMID: 34834200
PMC: 8622070.
DOI: 10.3390/pharmaceutics13111779.
Toh C, Siow T, Castillo M
Front Oncol. 2021; 11:725354.
PMID: 34722268
PMC: 8548359.
DOI: 10.3389/fonc.2021.725354.
Noncontrast assessment of blood-brain barrier permeability to water: Shorter acquisition, test-retest reproducibility, and comparison with contrast-based method.
Lin Z, Jiang D, Liu D, Li Y, Uh J, Hou X
Magn Reson Med. 2021; 86(1):143-156.
PMID: 33559214
PMC: 8466682.
DOI: 10.1002/mrm.28687.
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity.
Kadry H, Noorani B, Cucullo L
Fluids Barriers CNS. 2020; 17(1):69.
PMID: 33208141
PMC: 7672931.
DOI: 10.1186/s12987-020-00230-3.
Brain tumor vessels-a barrier for drug delivery.
Hempel C, Johnsen K, Kostrikov S, Hamerlik P, Andresen T
Cancer Metastasis Rev. 2020; 39(3):959-968.
PMID: 32488404
DOI: 10.1007/s10555-020-09877-8.
Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial.
Hanna C, Kurian K, Williams K, Watts C, Jackson A, Carruthers R
Neuro Oncol. 2020; 22(12):1840-1850.
PMID: 32347934
PMC: 7746945.
DOI: 10.1093/neuonc/noaa104.
Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
Zhang D, Dmello C, Chen L, Arrieta V, Gonzalez-Buendia E, Kane J
Clin Cancer Res. 2019; 26(2):477-486.
PMID: 31831565
PMC: 7050644.
DOI: 10.1158/1078-0432.CCR-19-2182.
Brain immunology and immunotherapy in brain tumours.
Sampson J, Gunn M, Fecci P, Ashley D
Nat Rev Cancer. 2019; 20(1):12-25.
PMID: 31806885
PMC: 7327710.
DOI: 10.1038/s41568-019-0224-7.
Claudin-3-deficient C57BL/6J mice display intact brain barriers.
Dias M, Coisne C, Lazarevic I, Baden P, Hata M, Iwamoto N
Sci Rep. 2019; 9(1):203.
PMID: 30659216
PMC: 6338742.
DOI: 10.1038/s41598-018-36731-3.
Bridging barriers: a comparative look at the blood-brain barrier across organisms.
OBrown N, Pfau S, Gu C
Genes Dev. 2018; 32(7-8):466-478.
PMID: 29692355
PMC: 5959231.
DOI: 10.1101/gad.309823.117.
Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Tong W, Alnakhli M, Bhardwaj R, Apostolou S, Sinha S, Fraser C
J Nanobiotechnology. 2018; 16(1):38.
PMID: 29653579
PMC: 5898074.
DOI: 10.1186/s12951-018-0365-y.
Non-contrast MR imaging of blood-brain barrier permeability to water.
Lin Z, Li Y, Su P, Mao D, Wei Z, Pillai J
Magn Reson Med. 2018; 80(4):1507-1520.
PMID: 29498097
PMC: 6097906.
DOI: 10.1002/mrm.27141.
Targeting Neoantigens in Glioblastoma: An Overview of Cancer Immunogenomics and Translational Implications.
Johanns T, Bowman-Kirigin J, Liu C, Dunn G
Neurosurgery. 2017; 64(CN_suppl_1):165-176.
PMID: 28899059
PMC: 6287409.
DOI: 10.1093/neuros/nyx321.
Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.
Cangalaya C, Bustos J, Calcina J, Vargas-Calla A, Mamani J, Suarez D
PLoS Negl Trop Dis. 2017; 11(6):e0005624.
PMID: 28575043
PMC: 5470720.
DOI: 10.1371/journal.pntd.0005624.
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.
Luedi M, Singh S, Mosley J, Hatami M, Gumin J, Sulman E
J Neurosurg Anesthesiol. 2016; 29(1):46-58.
PMID: 27653222
PMC: 5143186.
DOI: 10.1097/ANA.0000000000000368.
Perilesional Inflammation in Neurocysticercosis - Relationship Between Contrast-Enhanced Magnetic Resonance Imaging, Evans Blue Staining and Histopathology in the Pig Model.
Cangalaya C, Bustos J, Calcina J, Vargas-Calla A, Suarez D, Gonzalez A
PLoS Negl Trop Dis. 2016; 10(7):e0004869.
PMID: 27459388
PMC: 4961384.
DOI: 10.1371/journal.pntd.0004869.
Ferumoxytol-enhanced MRI differentiation of meningioma from dural metastases: a pilot study with immunohistochemical observations.
Hamilton B, Woltjer R, Prola-Netto J, Nesbit G, Gahramanov S, Pham T
J Neurooncol. 2016; 129(2):301-9.
PMID: 27393348
DOI: 10.1007/s11060-016-2175-0.
